Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interaction

This publication has 49 references indexed in Scilit:

• Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Apolipoprotein A-II modulates HDL remodeling in plasma
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I
  Archives of internal medicine (1960), 1991
• Apolipoprotein AIMilano. Partial lecithin: Cholesterol acyltransferase deficiency due to low levels of a functional enzyme
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Bezafibrate inhibits HMG-CoA reductase activity in incubated blood mononuclear cells from normal subjects and patients with heterozygous familial hypercholesterolaemia
  Pharmacological Research, 1989
• Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter study
  The American Journal of Cardiology, 1988
• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988
• Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia
  Atherosclerosis, 1985
• Pharmacokinetics of clofibrate in familial hypercholesterolemia
  Atherosclerosis, 1977
• The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972